ARTICLE | Clinical News
Alexion regulatory update
June 10, 1996 7:00 AM UTC
ALXN said U.S. Patent No. 5,523,226 issued, covering the composition of porcine embryonic stem cells. The patent, held by Biotechnology Research and Development Corp., is exclusively licensed to ALXN ...